Close

Novo Nordisk to Launch Novoeight® in the United States for People With Hemophilia A

Go back to Novo Nordisk to Launch Novoeight® in the United States for People With Hemophilia A
LINKEDIN CORPORATION (NYSE: LNKD) Delayed: 195.96 --0 (-0%)
Previous Close $195.96    52 Week High $254.98 
Open $0.13    52 Week Low $98.25 
Day High $195.96    P/E 852.00 
Day Low $195.96    EPS $0.23 
Volume 12,035,123